Back to top

The Zacks Analyst Blog Highlights: Johnson & Johnson, Ascena Retail, Financial Sector, Industrials and Health care

Read MoreHide Full Article

For Immediate Release

Chicago, IL – November 21, 2016 – announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Johnson & Johnson (NYSE:(JNJ - Free Report) Free Report), Ascena Retail (Nasdaq:(ASNA - Free Report) Free Report), Financial Sector (AMEX:XLFFree Report) , Industrials (AMEX:XLIFree Report) and Health care (AMEX:XLVFree Report ).

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.

Here are highlights from Friday’s Analyst Blog:

Trump Rotation Stocks to Buy Now

Boy am I glad that the election is finally over. I don’t know about you, but frankly I was sick and tired of hearing about Hillary’s emails and Trump’s grabby little hands. While most of my liberal friends are absolutely beside themselves, my unapologetic capitalist friends are ecstatic. There’s nothing that takes your mind off a rough week in politics like getting filthy rich.

Some serious head scratching took place as the Trump rotation began. The VIX had spiked following the reopening of Clinton’s email probe, implying the market was upset about the prospects of a Trump Presidency. However, since then, we’ve been in a rip your face off rally. And surprisingly it’s not in the stocks you’d think.

For example, Rogaine maker Johnson & Johnson (NYSE:(JNJ - Free Report) Free Report) has struggled to push above $120, selling off into the $115s over the last couple of days. There’s been virtually no improvement in tanning salons or hair dye either. Out of nowhere Pant suits have rallied. Lane Bryant parent company Ascena Retail (Nasdaq:(ASNA - Free Report) Free Report) is up big since the election. Rallying up from $5 to $6.44.

Big money has been rotating into the Financial Sector (AMEX:XLFFree Report) , Industrials (AMEX:XLIFree Report) and Health care (AMEX:XLVFree Report ) . The recent interest in health care is very surprising as you’d think Trump’s decision to repeal and replace Obamacare would hurt those stocks. However, don’t forget the witch hunt on Capitol Hill targeting drug companies that were hiking up prices. Under a Clinton regime, those stocks would have come under serious pressure to change their pricing policies. The election of Trump has caused a relief rally in drug stocks and given a shot in the arm to the entire sector.

Fund flows have been seen coming out of consumer discretionary which is exactly why I’m looking at stocks like Foot Locker which just reported an earnings beat earlier today. Foot Locker is a Zacks Rank #2 (Buy) stock right now. A big reason why is 4 analysts increasing their estimates of how much money they thing Foot Locker is going to make next year. The bullish attitude has pushed up our Zacks Consensus Estimate or the average of all these earnings guesses, up to $5.25 per share.

Every time you share this video, somebody who didn’t vote for Trump dries their tears with $100 bills. Chime in the comments section below, let me know what stocks you’re looking to buy as part of the Trump rotation. Subscribe to the YouTube channel, Twitter @bartosiastics and come back here for all the Trending Stocks with, I’m Dave Bartosiak.

Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1 Stock of the Day pick for free.

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Strong Stocks that Should Be in the News

Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year. See these high-potential stocks free >>.

Get the full Report on JNJ - FREE

Get the full Report on ASNA - FREE

Get the full Report on XLF - FREE

Get the full Report on XLI - FREE

Get the full Report on XLV - FREE

Follow us on Twitter:

Join us on Facebook:

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact
Zacks Investment Research
800-767-3771 ext. 9339

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss.

This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit for information about the performance numbers displayed in this press release.

More from Zacks Press Releases

You May Like